Telomir Pharmaceuticals, Inc.
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell TELO and other ETFs, options, and stocks.About TELO
Telomir Pharmaceuticals, Inc. is a pre-clinical-stage pharmaceutical company, which focuses on the development and commercialization of TELOMIR-1, a novel small molecule being developed to function as an oral in situ therapeutic treatment for human stem cells. The firm’s initial focus on treatments to inhibit the production of pro-inflammatory cytokines, such as IL-17, by oral administration of TELOMIR-1 as a therapeutic treatment for stem cells in situ.
TELO Key Statistics
Stock Snapshot
With a market cap of 87.34M, Telomir Pharmaceuticals, Inc.(TELO) trades at $1.27. The stock has a price-to-earnings ratio of -4.35.
As of 2026-07-05, Telomir Pharmaceuticals, Inc.(TELO) stock has fluctuated between $1.27 and $1.34. The current price stands at $1.27, placing the stock 0.0% above today's low and -5.2% off the high.
The Telomir Pharmaceuticals, Inc.(TELO)'s current trading volume is 46.98K, compared to an average daily volume of 182.2K.
In the last year, Telomir Pharmaceuticals, Inc.(TELO) shares hit a 52-week high of $3.10 and a 52-week low of $1.05.
In the last year, Telomir Pharmaceuticals, Inc.(TELO) shares hit a 52-week high of $3.10 and a 52-week low of $1.05.
People also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.